用户名:
密 码:
注册
|
忘记密码?
首 页
药品信息
药品检索
全部药品
适应症分类
热门药品
专利信息
专利检索
专利权人导航
专利权人分组导航
分类查询
IPC导航
热门检索
专利分析
概况
申请趋势分析
申请人分析
发明人分析
IPC分析
项目文档
项目
个人项目
文档
个人文档
企业文档
公共文档
标签
互动
特色功能
广州科技订制咨询
特色资讯
医药新闻
帮助中心
关于本软件
药品
文档
专利
新闻
所有专利
选择导航
专利权人导航
专利权人分组导航
分类导航
专利权人导航
SEPRACOR INC [US](13)
专利信息
Translation Company
查询条件
展开筛选条件
[专利权人] 包含 'SEPRACOR INC [US]'
[药品] 包含 'Lansoprazole '
清空条件
查询
分析
排序
公开日
公开号
申请日
申请号
中文标题
英文标题
降序
升序
翻到页码
标题
标题2
专利权人
发明人
附图
摘要
摘要2
优先权号
IPC
专利类型
首页
1
2
尾页
共
13
条记录, 当前第1/2页。
公开号
公开日
申请号
申请日
1.
US2004077688A1
2004/4/22
US20030685628
2003/10/14
专利标题
:Hydroxylansoprazole methods
专利权人
:
SEPRACOR INC [US]
;
Methods and compositions are disclosed utilizing hydroxylansoprazole for the treatment of ulcers in humans. Hydroxylansoprazole exhibits a lessened liability toward drug-drug interactions than lansoprazole and a more predictable dosing regimen than lansoprazole. Hydroxylansoprazole is also useful for the treatment of gastroesophageal reflux and other conditions related to gastric hypersecretion such as Zollinger-Ellison Syndrome.
2.
US2003008903A1
2003/1/9
US20020216962
2002/8/12
专利标题
:R-lansoprazole compositions and methods
专利权人
:
SEPRACOR INC [US]
;
Methods and compositions are disclosed utilizing optically pure (+) lansoprazole for the treatment of S ulcers in humans while substantially reducing the concomitant liability of adverse effects associated with the racemic mixture of lansoprazole. The optically pure (+) isomer is also useful for the treatment of gastroesophageal reflux. (+) Lansoprazole is an inhibitor of H+ release and is therefore useful in the treatment of other conditions related to gastric hypersecretion such as Zollinger-E...
3.
US2002099079A1
2002/7/25
US20010046464
2001/10/19
专利标题
:Hydroxylansoprazole methods
专利权人
:
SEPRACOR INC [US]
;
Methods and compositions are disclosed utilizing hydroxylansoprazole for the treatment of ulcers in humans. Hydroxylansoprazole exhibits a lessened liability toward drug-drug interactions than lansoprazole and a more predictable dosing regimen than lansoprazole. Hydroxylansoprazole is also useful for the treatment of gastroesophageal reflux and other conditions related to gastric hypersecretion such as Zollinger-Ellison Syndrome.
4.
US2002042433A1
2002/4/11
US20010981108
2001/10/17
专利标题
:R-lansoprazole compositions and methods
专利权人
:
SEPRACOR INC [US]
;
Methods and compositions are disclosed utilizing optically pure (+) lansoprazole for the treatment of ulcers in humans while substantially reducing the concomitant liability of adverse effects associated with the racemic mixture of lansoprazole. The optically pure (+) isomer is also useful for the treatment of gastroesophageal reflux. (+) Lansoprazole is an inhibitor of H+ release and is therefore useful in the treatment of other conditions related to gastric hypersecretion such as Zollinger-Ell...
5.
US6335351B1
2002/1/1
US19990357458
1999/7/20
专利标题
:Hydroxylansoprazole compositions and methods
专利权人
:
SEPRACOR INC [US]
;
Methods and compositions are disclosed utilizing hydroxylansoprazole for the treatment of ulcers in humans. Hydroxylansoprazole exhibits a lessened liability toward drug-drug interactions than lansoprazole and a more predictable dosing regimen than lansoprazole. Hydroxylansoprazole is also usefull for the treatment of gastroesophageal reflux and other conditions related to gastric hypersecretion such as Zollinger-Ellison Syndrome.
6.
EP1056457A1
2000/12/6
EP19990904418
1999/1/29
专利标题
:S-LANSOPRAZOLE COMPOSITIONS AND METHODS
专利权人
:
SEPRACOR INC [US]
;
7.
EP1056456A1
2000/12/6
EP19990903485
1999/1/29
专利标题
:R-LANSOPRAZOLE COMPOSITIONS AND METHODS
专利权人
:
SEPRACOR INC [US]
;
8.
WO0004904A1
2000/2/3
WO1999US16322
1999/7/19
专利标题
:PHARMACEUTICAL COMPOSITIONS COMPRISING HYDROXYLANSOPRAZOLE AND USES THEREOF
专利权人
:
SEPRACOR INC [US]
;
Methods and compositions are disclosed utilizing hydroxylansoprazole for the treatment of ulcers in humans. Hydroxylansoprazole exhibits a lessened liability toward drug-drug interactions than lansoprazole and a more predictable dosing regimen than lansoprazole. Hydroxylansoprazole is also useful for the treatment of gastroesophageal reflux and other conditions related to gastric hypersecretion such as Zollinger-Ellison Syndrome.
9.
CA2337886A1
2000/2/3
CA19992337886
1999/7/19
专利标题
:PHARMACEUTICAL COMPOSITIONS COMPRISING HYDROXYLANSOPRAZOLE AND USES THEREOF
专利权人
:
SEPRACOR INC [US]
;
Methods and compositions are disclosed utilizing hydroxylansoprazole for the treatment of ulcers in humans. Hydroxylansoprazole exhibits a lessened liability toward drug-drug interactions than lansoprazole and a more predictable dosing regimen than lansoprazole. Hydroxylansoprazole is also useful for the treatment of gastroesophageal reflux and other conditions related to gastric hypersecretion such as Zollinger-Ellison Syndrome.
10.
WO9938513A1
1999/8/5
WO1999US01938
1999/1/29
专利标题
:R-LANSOPRAZOLE COMPOSITIONS AND METHODS
专利权人
:
SEPRACOR INC [US]
;
Methods and compositions are disclosed utilizing optically pure (+) lansoprazole for the treatment of ulcers in humans while substantially reducing the concomitant liability of adverse effects associated with the racemic mixture of lansoprazole. The optically pure (+) isomer is also useful for the treatment of gastroesophageal reflux. (+) lansoprazole is an inhibitor of H<+> release and is therefore useful in the treatment of other conditions related to gastric hypersecretion such as Zollinger-E...
首页
1
2
尾页
共
13
条记录, 当前第1/2页。
当前查询条件: [专利权人] 包含 'SEPRACOR INC [US]'
AND
[药品] 包含 'Lansoprazole '
查询范围
在当前结果中查询
!
专利类型
发明
实用新型
外观设计
!
公开号
CN1234
!
申请号
CN1234
!
专利标题
扩展
PHARMA
!
专利权人
扩展
pfizer
发明人
!
申请日
yyyymmdd
!
公开日
yyyymmdd
优先权号
!
摘要
扩展
PHARMA
IPC
A01B
下载范围
下载第
到
条记录。
下载内容
题录信息
专利全文